Garetosmab
Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44. Garetosmab has potential anti-cancer activity and can be used to study ossifying fibrous dysplasia (FOP) and cancer.
Product Specifications
CAS Number
2097125-54-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TGF-beta/Smad
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AM1412 2 OD, 4 OD, 50 OD
MIRacle™ hsa-miR-6738-3p miRNA Agomir/Antagomir
Sign In for Pricing
View Details 
MBS1484651-01 0.02 mg (E-Coli)
Recombinant Pseudomonas syringae pv. phaseolicola UPF0270 protein PSPPH_1506 (PSPPH_1506)
Sign In for Pricing
View Details MBS1484651-02 0.1 mg (E-Coli)
Recombinant Pseudomonas syringae pv. phaseolicola UPF0270 protein PSPPH_1506 (PSPPH_1506)
Sign In for Pricing
View Details MBS1484651-03 0.02 mg (Yeast)
Recombinant Pseudomonas syringae pv. phaseolicola UPF0270 protein PSPPH_1506 (PSPPH_1506)
Sign In for Pricing
View Details